Cargando…

Altered plasma cytokines in dogs with atopic dermatitis

BACKGROUND: Canine (Canis lupus familiaris) atopic dermatitis (AD) shares similar clinical signs to human AD. The abnormal immune response of AD is orchestrated by T lymphocytes, and may include variable involvement of cytokines, regulatory T (Treg) cells, eosinophils, mast cells and other immune co...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazrier, Hamutal, Vogelnest, Linda J., Taylor, Rosanne M., Williamson, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299684/
https://www.ncbi.nlm.nih.gov/pubmed/34817106
http://dx.doi.org/10.1111/vde.13044
_version_ 1784751031700160512
author Mazrier, Hamutal
Vogelnest, Linda J.
Taylor, Rosanne M.
Williamson, Peter
author_facet Mazrier, Hamutal
Vogelnest, Linda J.
Taylor, Rosanne M.
Williamson, Peter
author_sort Mazrier, Hamutal
collection PubMed
description BACKGROUND: Canine (Canis lupus familiaris) atopic dermatitis (AD) shares similar clinical signs to human AD. The abnormal immune response of AD is orchestrated by T lymphocytes, and may include variable involvement of cytokines, regulatory T (Treg) cells, eosinophils, mast cells and other immune components. Helper T (Th)2 cytokines often predominate initially, followed by Th1 cytokines in more chronic phases. HYPOTHESIS/OBJECTIVES: Pro‐inflammatory and Treg cytokines have been shown to play a role in human AD, yet their importance is not clear in canine AD. Hence, this study aimed to measure the concentrations of cytokines/chemokines not traditionally associated with Th1/Th2 response. ANIMALS: Canine AD patients (n = 27), compared to control dogs (n = 11). METHODS AND MATERIALS: A total of 19 plasma cytokines were assayed using canine specific multiplex immuno‐assays. RESULTS: The plasma concentrations of CXC Motif Chemokine Ligand 8 (CXCL8), interleukin (IL)‐7 and IL‐15 cytokines were elevated in canine AD patients, compared to control dogs. In addition, stem‐cell factor (SCF) concentrations were reduced in the plasma of canine AD patients compared to control dogs. Distinct cytokine profiles were found in dogs belonging to the Staffordshire breeds, a group with increased risk of AD. In particular, granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) had significantly elevated concentrations. CONCLUSIONS AND CLINICAL RELEVANCE: Some of the plasma cytokine alterations in canine AD described here, particularly of IL‐7, have not been reported previously. Monitoring these distinctive cytokine alterations could be useful for diagnosis and monitoring of canine AD in dogs.
format Online
Article
Text
id pubmed-9299684
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92996842022-07-21 Altered plasma cytokines in dogs with atopic dermatitis Mazrier, Hamutal Vogelnest, Linda J. Taylor, Rosanne M. Williamson, Peter Vet Dermatol Hypersensitivity Disorders BACKGROUND: Canine (Canis lupus familiaris) atopic dermatitis (AD) shares similar clinical signs to human AD. The abnormal immune response of AD is orchestrated by T lymphocytes, and may include variable involvement of cytokines, regulatory T (Treg) cells, eosinophils, mast cells and other immune components. Helper T (Th)2 cytokines often predominate initially, followed by Th1 cytokines in more chronic phases. HYPOTHESIS/OBJECTIVES: Pro‐inflammatory and Treg cytokines have been shown to play a role in human AD, yet their importance is not clear in canine AD. Hence, this study aimed to measure the concentrations of cytokines/chemokines not traditionally associated with Th1/Th2 response. ANIMALS: Canine AD patients (n = 27), compared to control dogs (n = 11). METHODS AND MATERIALS: A total of 19 plasma cytokines were assayed using canine specific multiplex immuno‐assays. RESULTS: The plasma concentrations of CXC Motif Chemokine Ligand 8 (CXCL8), interleukin (IL)‐7 and IL‐15 cytokines were elevated in canine AD patients, compared to control dogs. In addition, stem‐cell factor (SCF) concentrations were reduced in the plasma of canine AD patients compared to control dogs. Distinct cytokine profiles were found in dogs belonging to the Staffordshire breeds, a group with increased risk of AD. In particular, granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) had significantly elevated concentrations. CONCLUSIONS AND CLINICAL RELEVANCE: Some of the plasma cytokine alterations in canine AD described here, particularly of IL‐7, have not been reported previously. Monitoring these distinctive cytokine alterations could be useful for diagnosis and monitoring of canine AD in dogs. John Wiley and Sons Inc. 2021-11-24 2022-04 /pmc/articles/PMC9299684/ /pubmed/34817106 http://dx.doi.org/10.1111/vde.13044 Text en © 2021 The Authors. Veterinary Dermatology published by John Wiley & Sons Ltd on behalf of ESVD and ACVD https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Hypersensitivity Disorders
Mazrier, Hamutal
Vogelnest, Linda J.
Taylor, Rosanne M.
Williamson, Peter
Altered plasma cytokines in dogs with atopic dermatitis
title Altered plasma cytokines in dogs with atopic dermatitis
title_full Altered plasma cytokines in dogs with atopic dermatitis
title_fullStr Altered plasma cytokines in dogs with atopic dermatitis
title_full_unstemmed Altered plasma cytokines in dogs with atopic dermatitis
title_short Altered plasma cytokines in dogs with atopic dermatitis
title_sort altered plasma cytokines in dogs with atopic dermatitis
topic Hypersensitivity Disorders
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299684/
https://www.ncbi.nlm.nih.gov/pubmed/34817106
http://dx.doi.org/10.1111/vde.13044
work_keys_str_mv AT mazrierhamutal alteredplasmacytokinesindogswithatopicdermatitis
AT vogelnestlindaj alteredplasmacytokinesindogswithatopicdermatitis
AT taylorrosannem alteredplasmacytokinesindogswithatopicdermatitis
AT williamsonpeter alteredplasmacytokinesindogswithatopicdermatitis